American Century Companies’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.6M | Buy |
141,510
+16,481
| +13% | +$1.06M | ﹤0.01% | 1538 |
|
|
2026
Q1 | $7.05M | Buy |
125,029
+55,192
| +79% | +$3.59M | ﹤0.01% | 1616 |
|
|
2025
Q4 | $5.6M | Buy |
69,837
+8,207
| +13% | +$551K | ﹤0.01% | 1689 |
|
|
2025
Q3 | $3M | Buy |
61,630
+51,514
| +509% | +$3.19M | ﹤0.01% | 1916 |
|
|
2025
Q2 | $755K | Buy |
10,116
+86
| +0.9% | +$5.69K | ﹤0.01% | 2384 |
|
|
2025
Q1 | $637K | Sell |
10,030
-2,244
| -18% | -$153K | ﹤0.01% | 2414 |
|
|
2024
Q4 | $958K | Sell |
12,274
-234
| -2% | -$18.8K | ﹤0.01% | 2270 |
|
|
2024
Q3 | $1.01M | Sell |
12,508
-7,423
| -37% | -$600K | ﹤0.01% | 2234 |
|
|
2024
Q2 | $1.65M | Sell |
19,931
-1,066
| -5% | -$93.8K | ﹤0.01% | 1981 |
|
|
2024
Q1 | $1.79M | Sell |
20,997
-22,572
| -52% | -$1.77M | ﹤0.01% | 1926 |
|
|
2023
Q4 | $3.73M | Buy |
43,569
+16,261
| +60% | +$1.41M | ﹤0.01% | 1508 |
|
|
2023
Q3 | $2.45M | Buy |
27,308
+7,490
| +38% | +$669K | ﹤0.01% | 1618 |
|
|
2023
Q2 | $1.69M | Buy |
19,818
+5,775
| +41% | +$488K | ﹤0.01% | 1717 |
|
|
2023
Q1 | $1.13M | Buy |
14,043
+1,017
| +8% | +$82.3K | ﹤0.01% | 1817 |
|
|
2022
Q4 | $1.02M | Buy |
13,026
+2,248
| +21% | +$181K | ﹤0.01% | 1797 |
|
|
2022
Q3 | $798K | Buy |
10,778
+2,356
| +28% | +$169K | ﹤0.01% | 1781 |
|
|
2022
Q2 | $549K | Sell |
8,422
-8,985
| -52% | -$532K | ﹤0.01% | 1886 |
|
|
2022
Q1 | $1.1M | Buy |
17,407
+10,802
| +164% | +$587K | ﹤0.01% | 1642 |
|
|
2021
Q4 | $350K | Buy |
6,605
+1,521
| +30% | +$92.7K | ﹤0.01% | 2062 |
|
|
2021
Q3 | $359K | Buy |
5,084
+607
| +14% | +$38.3K | ﹤0.01% | 2015 |
|
|
2021
Q2 | $298K | Buy |
4,477
+1,250
| +39% | +$88.5K | ﹤0.01% | 2079 |
|
|
2021
Q1 | $358K | Buy |
+3,227
| New | +$399K | ﹤0.01% | 1843 |
|
|
2019
Q4 | – | Sell |
-925,833
| Closed | -$117M | – | 1523 |
|
|
2019
Q3 | $117M | Buy |
925,833
+6,127
| +0.7% | +$778K | 0.12% | 219 |
|
|
2019
Q2 | $111M | Buy |
919,706
+84,895
| +10% | +$8.35M | 0.11% | 240 |
|
|
2019
Q1 | $73M | Buy |
834,811
+58,856
| +8% | +$5.35M | 0.07% | 302 |
|
|
2018
Q4 | $77.6M | Sell |
775,955
-229,829
| -23% | -$24.1M | 0.09% | 272 |
|
|
2018
Q3 | $115M | Buy |
1,005,784
+701,976
| +231% | +$72.7M | 0.11% | 239 |
|
|
2018
Q2 | $27.2M | Buy |
303,808
+184,324
| +154% | +$15.6M | 0.03% | 465 |
|
|
2018
Q1 | $8.74M | Sell |
119,484
-73,529
| -38% | -$5.04M | 0.01% | 674 |
|
|
2017
Q4 | $11.2M | Buy |
193,013
+143,309
| +288% | +$7.55M | 0.01% | 621 |
|
|
2017
Q3 | $2.23M | Buy |
49,704
+3,433
| +7% | +$143K | ﹤0.01% | 1014 |
|
|
2017
Q2 | $1.83M | Buy |
46,271
+425
| +0.9% | +$17.5K | ﹤0.01% | 1052 |
|
|
2017
Q1 | $1.86M | Buy |
45,846
+405
| +0.9% | +$15.8K | ﹤0.01% | 1054 |
|
|
2016
Q4 | $1.83M | Buy |
+45,441
| New | +$1.71M | ﹤0.01% | 1052 |
|
|
2016
Q3 | – | Sell |
-258,474
| Closed | -$7.49M | – | 1364 |
|
|
2016
Q2 | $7.49M | Sell |
258,474
-309,844
| -55% | -$9.37M | 0.01% | 723 |
|
|
2016
Q1 | $19.9M | Sell |
568,318
-24,702
| -4% | -$798K | 0.02% | 510 |
|
|
2015
Q4 | $19.1M | Buy |
593,020
+83,474
| +16% | +$2.71M | 0.02% | 511 |
|
|
2015
Q3 | $16.5M | Buy |
509,546
+15,116
| +3% | +$569K | 0.02% | 549 |
|
|
2015
Q2 | $20.4M | Sell |
494,430
-70,610
| -12% | -$2.98M | 0.02% | 546 |
|
|
2015
Q1 | $25.4M | Sell |
565,040
-275,778
| -33% | -$11.5M | 0.03% | 494 |
|
|
2014
Q4 | $31.5M | Sell |
840,818
-121,905
| -13% | -$4.47M | 0.04% | 464 |
|
|
2014
Q3 | $33.6M | Buy |
962,723
+46,258
| +5% | +$1.65M | 0.04% | 437 |
|
|
2014
Q2 | $32.3M | Buy |
916,465
+730,560
| +393% | +$24.4M | 0.04% | 449 |
|
|
2014
Q1 | $6.06M | Buy |
+185,905
| New | +$7.1M | 0.01% | 853 |
|
|
2013
Q4 | – | Sell |
-45,180
| Closed | -$1.8M | – | 1464 |
|
|
2013
Q3 | $1.8M | Sell |
45,180
-24,580
| -35% | -$1.03M | ﹤0.01% | 1120 |
|
|
2013
Q2 | $2.88M | Buy |
+69,760
| New | +$2.82M | ﹤0.01% | 998 |
|
Other funds holding HAE
AI
American Century Companies's HAE Position: Q2 2026 in Review
American Century Companies increased its Haemonetics (HAE) stake by 13% in Q2 2026, buying an estimated $1.06M and bringing the position to 141,510 shares worth $10.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1538.
American Century Companies first reported a position in HAE in Q2 2013 and has held it in 46 quarters since. The position peaked at $117M in Q3 2019. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.
- American Century Companies held 141,510 shares of Haemonetics worth $10.6M as of Q2 2026.
- American Century Companies bought 16,481 Haemonetics shares in Q2 2026, an estimated $1.06M.
- Haemonetics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1538 holding.
- American Century Companies first reported a position in Haemonetics in Q2 2013 and has held it in 46 quarters since.
- American Century Companies's Haemonetics position peaked at $117M in Q3 2019.
- 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.
Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.